Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11149 - 11149
Published: Oct. 17, 2024
Rheumatoid
arthritis
(RA)
patients
face
different
health
challenges
when
infected
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
than
the
general
population,
due
to
both
their
immunocompromised
state
and
immunosuppressive
therapies
they
receive.
This
systematic
literature
review,
which
follows
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
(PRISMA)
paradigm,
explores
interactions
between
RA
SARS-CoV-2
infection,
focusing
on
immunologic
issues,
disease
management,
vaccination,
adverse
outcomes.
In
order
obtain
most
relevant
information,
we
systematically
reviewed
specific
from
1
January
2021
31
December
2023,
based
PRISMA
method,
by
eventually
selected
35
eligible
articles,
added
other
ISI-indexed
studies
enrich
our
results
further.
Consequently,
performed
a
funnel
analysis
evaluate
potential
publication
bias.
Firstly,
data
collected
revealed
impact
of
pandemic
diagnoses
fear
face-to-face
medical
consultations
that
delayed
adequate
treatment.
Secondly,
cardiovascular
metabolic
comorbidities
increase
risk
prolonged
COVID-19
symptoms,
hospitalization,
outcomes
patients.
With
respect
treatment
used
control
RA,
it
was
observed
glucocorticoids
(especially
high-dose
usage)
Rituximab
(RTX)
predispose
poor
outcomes,
as
opposed
Baricitinib
interleukin-6
(IL-6)
tumor
necrosis
factor-alpha
(TNF-α)
inhibitors.
vaccination
has
proven
effective
generally
safe
in
some
studies,
although
Methotrexate
(MTX),
Abatacept
(ABA),
RTX
have
been
associated
impaired
vaccine
immune
response.
review
brings
updated
thorough
information
immunological,
clinical,
management
complex
immune-mediated
inflammatory
(IMID)
like
setting
underlines
faced
this
group
The
lessons
learned
can
be
extended
beyond
shaping
more
informed
compassionate
healthcare
system
offering
long-term
care
RA.
Language: Английский
A Systematic Review and Meta-Analysis on Opioid Management of Dyspnea in Cancer Patients
Cancers,
Journal Year:
2025,
Volume and Issue:
17(8), P. 1368 - 1368
Published: April 19, 2025
Background/Objectives:
Dyspnea
accompanies
end-of-life
in
many
cancer
patients,
with
around
50%
experiencing
moderate/severe
dyspnea,
and
is
an
independent
factor
for
poor
prognosis
declining
quality
of
life.
Managing
dyspnea
becomes
a
key
component
palliative
treatment
support
patients.
Opioids
seem
to
be
the
obvious
choice
patients
as
they
also
address
pain
(often
important
such
patients).
Evidence-based
conclusions
on
effectiveness/safety
opioids
management
are
scarce,
results
still
controversial.
We
aim
this
knowledge
gap.
Methods:
In
order
achieve
objective
paper,
we
conducted
comprehensive
search
international
databases
(PubMed,
Medline,
Embase,
Cochrane
Library)
randomized
controlled
trials
use
treat
refractory
adult
performed
pooled
meta-analysis
results.
Results:
The
effect
relief
was
significant
(SMD
−0.44,
95%
CI
[−0.75,−0.12],
p
=
0.007).
significance
opioid
maintained
only
morphine
administration
−078,
[−1.45,−0.10],
0.02)
exertional
−1.00,
[−1.98,
−0.03],
0.04).
No
correlation
noted
between
fentanyl/hydromorphone
or
administered
at
rest.
subcutaneous
route
seems
significantly
correlated
−0.73,
[−1.27,
−0.19],
0.008),
while
other
modalities
lack
effect.
present
usage
morphine/fentanyl
increased
odds
severe
adverse
effects
(OR
1.48,
[0.57,3.86],
0.42);
however,
fentanyl
associated
somnolence.
Although
aimed
evaluate
how
impact
life
were
unable
obtain
due
absolute
literature
available
discussing
QoL.
Conclusions:
managed
provide
some
insights
into
efficiency
safety
evidence
based
low
grade.
There
marked
need
gap
future
high-quality
studies
large
sample
sizes
standardized
protocols.
Language: Английский
Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 22, 2025
Language: Английский
Vitamins, Coenzyme Q10, and Antioxidant Strategies to Improve Oocyte Quality in Women with Gynecological Cancers: A Comprehensive Review
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1567 - 1567
Published: Dec. 19, 2024
Background:
Gynecological
cancers,
including
ovarian,
cervical,
and
endometrial
significantly
affect
both
survival
reproductive
health
in
women.
Cancer
treatments
such
as
chemotherapy
radiotherapy
can
impair
ovarian
function,
reducing
oocyte
quality
fertility
potential.
Objective:
This
review
aims
to
evaluate
how
vitamins
antioxidants
enhance
preservation
outcomes
for
women
diagnosed
with
gynecological
particularly
the
context
of
assisted
technologies
(ART).
Standard
these
hysterectomy,
bilateral
salpingo-oophorectomy,
radiation,
chemotherapy,
often
compromise
function
quality.
focuses
on
potential
role
interventions
improving
quality,
thereby
supporting
successful
ART
outcomes.
Methods:
A
comprehensive
narrative
current
literature
was
conducted,
examining
effects
A,
C,
D3,
E,
Coenzyme
Q10
oxidative
stress
inflammation
induced
by
cancer
its
treatments.
Results:
The
evidence
suggests
that
certain
may
mitigate
damage
Vitamin
supports
cumulus–oocyte
complex
integrity,
while
C
E
act
potent
antioxidants,
tissues.
D3
enhances
reserve
markers
modulates
inflammatory
cytokines.
improves
mitochondrial
reduces
DNA
damage,
increasing
viability
fertilization
Conclusions:
incorporation
specific
into
strategies
cancers.
Although
preliminary
findings
are
promising,
further
research
is
needed
determine
optimal
dosages
establish
standardized
protocols
clinical
use.
Language: Английский
Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers—Last Resort or Therapeutic Option?
Vlad Rotaru,
No information about this author
Elena Chitoran,
No information about this author
Daniela-Luminita Zob
No information about this author
et al.
Diagnostics,
Journal Year:
2024,
Volume and Issue:
14(16), P. 1707 - 1707
Published: Aug. 6, 2024
First
described
some
80
years
ago,
pelvic
exenteration
remain
controversial
interventions
with
variable
results
and
ever-changing
indications.
The
previous
studies
are
not
homogenous
have
different
inclusion
criteria
(different
populations
disease
characteristics)
methodologies
(including
evaluation
of
results),
making
it
extremely
difficult
to
properly
assess
the
role
in
cancer
treatment.
This
study
aims
describe
indications
exenterations,
main
prognostic
factors
oncologic
results,
possible
complications
intervention.
Language: Английский
Cardiovascular Mortality in Patients with Gynecological Cancers: A Population-based Cohort Study
Yue Yang,
No information about this author
Jun-Ping Yang,
No information about this author
Bing-Shu Li
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 14, 2024
ABSTRACT
Objective
The
survival
rate
of
gynecological
cancers
(GCs)
has
improved
significantly
in
recent
decades.
Patients
with
GCs
did
not
necessarily
succumb
to
the
primary
cancer.
Cardiovascular
health
might
be
a
critical
determinant
long-term
survival.
This
study
aimed
investigate
mortality
and
risk
factors
associated
cardiovascular
disease
(CVD)
death
patients
GCs.
Methods
A
total
399,399
cases
diagnosed
between
2000
2020
from
Surveillance,
Epidemiology,
End
Results
(SEER)
database
were
included
this
study.
standardized
ratio
(SMR)
for
CVD
was
estimated.
Prognostic
assessed
using
cause-specific
hazard
ratios
95%
confidence
intervals
within
competing
model,
considering
non-cardiovascular
as
risk.
Of
GCs,
117,551
(29%)
died
16,371
(4.1%)
CVD.
deaths,
73.2%
attributed
heart
disease.
SMR
highest
survivors
before
age
45
years,
remained
elevated
throughout
follow-up
period
compared
general
United
States
(US)
population.
In
SMRs
increased
steadily
all
subtypes
except
vulvar
Older
age,
black
race,
localized
stage,
unmarried/single/divorced,
vaginal
cancers,
radiation
therapy
higher
mortality.
nomogram
developed
validated
these
variables
predict
Conclusions
US
constructed
forecast
individuals
More
attention
should
paid
during
diagnosis
improve
rates.
HIGHLIGHTS
⇒
29%
cancer,
while
4.1%
CVD,
deaths
across
GC
subtypes,
Higher
linked
older
unmarried/single/divorced
status,
prior
therapy,
especially
cancers.
We
patients,
aiding
personalized
patient
management.
Language: Английский
Gynecological Insights into Lynch Syndrome—A Comprehensive Review of Cancer Screening and Prevention
Medicina,
Journal Year:
2024,
Volume and Issue:
60(12), P. 2013 - 2013
Published: Dec. 6, 2024
Lynch
syndrome,
one
of
the
most
common
genetic
syndromes
predisposing
to
cancer,
is
associated
with
a
series
malignant
conditions,
among
which
frequent
colorectal
but
gynecologic
cancers
(especially
endometrial)
are
also
quite
common.
Despite
significant
progress
made
in
understanding
this
condition
over
time,
there
still
aspects
managing
that
have
not
demonstrated
clear
benefits.
This
article
aims
summarize
recommendations
international
societies
and
present
latest
developments
focusing
on
cancer
screening
possible
prevention
strategies.
Advances
testing
procedures
discoveries
related
association
between
oncological
pathology
frequency
affected
pathogenic
variant
type
will
probably
lead
personalized
medicine
focused
individual
patient
coming
years.
Although
various
methods
for
gynecological
patients
syndrome
been
used
they
shown
survival
highlights
need
studying
implementing
new
diagnostic
methods,
under
investigation
recent
years
mentioned
article.
Language: Английский